Group size (n) |
30 |
30 |
16 |
30 |
Mean age in years (± SD) |
38 (± 9) |
35 (± 12) |
41 (± 10) |
34 (± 12) |
Sex, female |
73% |
70% |
75% |
73% |
Mean time between SARS-CoV-2 infection and study inclusion in
days (± SD) |
260 (± 104) |
276 (± 142) |
- |
- |
Asymptomatic/mild COVID-19 |
87% |
93% |
- |
- |
SARS-CoV-2 vaccination |
67% |
97% |
75% |
97% |
Vaccinated before first SARS-CoV-2 infection |
0% |
40% |
- |
- |